Evidence map›Paper›PMID 26458046›Full record

ArticleNature structural & molecular biology2015

The chaperone αB-crystallin uses different interfaces to capture an amorphous and an amyloid client.

Andi Mainz, Jirka Peschek, Maria Stavropoulou, Katrin C Back, Benjamin Bardiaux, Sam Asami, Elke Prade, Carsten Peters, Sevil Weinkauf, Johannes Buchner and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 155 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Formation of a β-Endorphin Corona Mitigates Alzheimer's Amyloidogenesis.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  8. Activation mechanism of small heat shock protein HSPB5 revealed by disease-associated mutants.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Amyloid inhibition by molecular chaperonesRSC medicinal chemistry · 2023
    Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Andi MainzMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Jirka PeschekMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Maria StavropoulouMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Katrin C BackMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Benjamin BardiauxUnité de Bioinformatique Structurale, Institut Pasteur, Paris, France.ORCID http://orcid.org/0000-0003-4014-9195
Sam AsamiMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Elke PradeMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Carsten PetersMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Sevil WeinkaufMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Johannes BuchnerMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Bernd ReifMunich Center for Integrated Protein Science at Department Chemie, Technische Universität München, Garching, Germany.
Center for Integrated Protein Science Munich · DEInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small heat-shock proteins, including αB-crystallin (αB), play an important part in protein homeostasis, because their ATP-independent chaperone activity inhibits uncontrolled protein aggregation. Mechanistic details of human αB, particularly in its client-bound state, have been elusive so far, owing to the high molecular weight and the heterogeneity of these complexes. Here we provide structural insights into this highly dynamic assembly and show, by using state-of-the-art NMR spectroscopy, that the αB complex is assembled from asymmetric building blocks. Interaction studies demonstrated that the fibril-forming Alzheimer's disease Aβ1-40 peptide preferentially binds to a hydrophobic edge of the central β-sandwich of αB. In contrast, the amorphously aggregating client lysozyme is captured by the partially disordered N-terminal domain of αB. We suggest that αB uses its inherent structural plasticity to expose distinct binding interfaces and thus interact with a wide range of structurally variable clients.

Indexed as

alpha-Crystallin B ChainAmyloidHumansMagnetic Resonance SpectroscopyModels, BiologicalModels, MolecularProtein BindingProtein Conformationalpha-Crystallin B ChainAmyloid

Identifiers

PMID26458046
OpenAlexW2338903889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.